McEwen (MUX) Financials

$10.21 -0.53 (-4.93%)

Closing price 03:59 PM Eastern

Extended Trading

$10.20 -0.01 (-0.05%)

As of 06:45 PM Eastern

Annual Income Statements for McEwen

This table shows McEwen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-81	55	-44
Consolidated Net Income / (Loss)	-86	33	-44
Net Income / (Loss) Continuing Operations	-86	33	-44
Total Pre-Tax Income	-80	67	-47
Total Operating Income	-95	-162	-51
Total Gross Profit	-0.54	18	31
Total Revenue	110	166	174
Operating Revenue	110	166	174
Total Cost of Revenue	111	148	144
Operating Cost of Revenue	111	148	144
Total Operating Expenses	95	180	82
Selling, General & Admin Expense	12	15	17
Exploration Expense	15	20	17
Depreciation Expense	0.73	1.14	0.63
Other Operating Expenses / (Income)	67	143	47
Total Other Income / (Expense), net	15	229	3.83
Interest Expense	7.79	-37	4.60
Interest & Investment Income	0.00	222	0.00
Other Income / (Expense), net	23	-30	8.43
Income Tax Expense	5.81	34	-3.05
Net Income / (Loss) Attributable to Noncontrolling Interest	-5.02	-22	0.00
Basic Earnings per Share	($1.71)	$1.16	($0.86)
Weighted Average Basic Shares Outstanding	47.43M	47.54M	51.02M
Diluted Earnings per Share	($1.71)	$1.16	($0.86)
Weighted Average Diluted Shares Outstanding	47.43M	47.54M	51.02M
Weighted Average Basic & Diluted Shares Outstanding	47.43M	49.44M	53.93M

This table shows McEwen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-11	-37	-43	-22	-18	138	-20	-13	-2.08	-8.23
Consolidated Net Income / (Loss)	-11	-42	-36	-43	-28	141	-20	-13	-2.08	-8.23
Net Income / (Loss) Continuing Operations	-11	-42	-36	-43	-28	141	-20	-13	-2.08	-8.23
Total Pre-Tax Income	-11	-35	-37	-45	-29	178	-23	-15	-1.27	-7.16
Total Operating Income	-16	-39	-43	-43	-29	-47	-22	-14	-0.10	-15
Total Gross Profit	1.50	-0.29	4.44	-3.47	3.76	13	6.01	11	14	0.36
Total Revenue	26	28	35	34	38	59	41	47	52	34
Operating Revenue	26	28	35	34	38	59	41	47	52	34
Total Cost of Revenue	24	29	30	38	35	46	35	37	38	33
Operating Cost of Revenue	24	29	30	38	35	46	35	37	38	33
Total Operating Expenses	17	39	47	40	33	60	28	25	14	15
Selling, General & Admin Expense	4.35	3.10	3.44	2.05	3.72	6.24	4.07	4.46	2.14	6.49
Exploration Expense	3.93	3.54	5.90	5.85	4.67	3.74	3.87	4.98	5.33	2.36
Depreciation Expense	0.21	0.24	0.28	0.31	0.33	0.22	0.17	0.16	0.16	0.15
Other Operating Expenses / (Income)	8.59	32	38	31	24	50	20	15	6.28	5.91
Total Other Income / (Expense), net	4.51	4.24	5.89	-2.30	0.22	225	-0.96	-1.42	-1.17	7.39
Interest Expense	1.82	2.69	-8.46	-20	-10	1.45	0.87	1.73	1.08	0.91
Other Income / (Expense), net	6.33	6.94	-2.58	-22	-10	4.59	-0.09	0.31	-0.09	8.29
Income Tax Expense	-0.52	7.14	-0.54	-2.05	-0.24	37	-2.56	-2.38	0.81	1.07
Basic Earnings per Share	($0.22)	($0.79)	($0.91)	($0.46)	($0.39)	$2.91	($0.41)	($0.26)	($0.04)	($0.15)
Weighted Average Basic Shares Outstanding	47.43M	47.43M	47.43M	47.43M	47.47M	47.54M	49.44M	49.72M	51.95M	51.02M
Diluted Earnings per Share	($0.22)	($0.79)	($0.91)	($0.46)	($0.39)	$2.91	($0.41)	($0.26)	($0.04)	($0.15)
Weighted Average Diluted Shares Outstanding	47.43M	47.43M	47.43M	47.43M	47.47M	47.54M	49.44M	49.72M	51.95M	51.02M
Weighted Average Basic & Diluted Shares Outstanding	47.43M	47.43M	47.43M	47.47M	47.49M	49.44M	49.44M	51.09M	52.92M	53.93M

This table details how cash moves in and out of McEwen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-17	-16	-10
Net Cash From Operating Activities	-57	-40	29
Net Cash From Continuing Operating Activities	-57	-40	29
Net Income / (Loss) Continuing Operations	-86	33	-44
Consolidated Net Income / (Loss)	-86	33	-44
Depreciation Expense	20	30	31
Non-Cash Adjustments To Reconcile Net Income	5.42	-85	30
Changes in Operating Assets and Liabilities, net	4.57	-18	12
Net Cash From Investing Activities	-24	-100	-58
Net Cash From Continuing Investing Activities	-24	-100	-58
Purchase of Property, Plant & Equipment	-24	-26	-43
Acquisitions	0.00	-46	-14
Purchase of Investments	0.00	-34	-0.37
Divestitures	0.00	0.00	1.13
Sale and/or Maturity of Investments	0.00	6.03	0.00
Other Investing Activities, net	0.29	0.00	-1.72
Net Cash From Financing Activities	65	172	19
Net Cash From Continuing Financing Activities	65	172	19
Repayment of Debt	0.00	-25	0.00
Issuance of Debt	15	0.00	0.00
Issuance of Common Equity	14	13	20
Other Financing Activities, net	36	184	-1.22
Effect of Exchange Rate Changes	-2.03	-49	-0.66
Cash Interest Paid	4.88	4.73	3.91
Cash Income Taxes Paid	0.02	1.41	0.71

This table details how cash moves in and out of McEwen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	11	-15	151	-106	-36	-26	-1.09	17	-11	-15
Net Cash From Operating Activities	-10	6.04	-19	-34	-2.28	16	3.88	3.61	23	-1.21
Net Cash From Continuing Operating Activities	-10	6.04	-19	-34	-2.28	16	3.88	3.61	23	-1.21
Net Income / (Loss) Continuing Operations	-11	-42	-36	-43	-28	141	-20	-13	-2.08	-8.23
Consolidated Net Income / (Loss)	-11	-42	-36	-43	-28	141	-20	-13	-2.08	-8.23
Depreciation Expense	4.67	7.37	7.26	8.52	8.51	6.07	7.44	7.65	8.92	6.85
Non-Cash Adjustments To Reconcile Net Income	-4.35	17	12	15	14	-126	15	11	3.91	0.40
Changes in Operating Assets and Liabilities, net	-0.07	23	-2.75	-14	3.98	-4.96	2.03	-1.97	12	-0.24
Net Cash From Investing Activities	-8.89	-7.05	-4.95	-31	-16	-47	-4.58	-6.55	-34	-13
Net Cash From Continuing Investing Activities	-8.89	-7.05	-4.95	-31	-16	-48	-4.58	-6.55	-34	-13
Purchase of Property, Plant & Equipment	-8.89	-7.05	-4.95	-4.01	-9.32	-7.82	-4.52	-6.68	-19	-13
Purchase of Investments	-	-	0.00	-27	-7.05	-0.25	-0.05	0.05	-0.08	-0.29
Divestitures	-	-	-	-	-	-	-	-	-	-0.00
Sale and/or Maturity of Investments	-	-0.29	0.00	-	-	6.03	0.00	0.08	-	-0.08
Other Investing Activities, net	-	-	-	-	-	-	-	-	-	0.22
Net Cash From Financing Activities	26	0.00	185	-26	-0.56	13	-0.14	20	-0.50	-0.33
Net Cash From Continuing Financing Activities	26	0.00	185	-26	-0.56	13	-0.14	20	-0.50	-0.33
Other Financing Activities, net	26	0.00	185	-0.54	-0.56	-0.13	-0.14	-0.24	-0.50	-0.33
Effect of Exchange Rate Changes	-	-14	-9.11	-16	-16	-7.79	-0.26	-0.45	0.42	-0.38
Cash Interest Paid	1.48	0.57	1.25	32	13	-41	0.97	1.60	1.09	0.25
Cash Income Taxes Paid	-	0.02	-	-	0.99	-4.33	-	-	-	0.31

This table presents McEwen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	529	657	665
Total Current Assets	82	53	41
Cash & Equivalents	40	23	14
Short-Term Investments	1.30	1.74	1.62
Note & Lease Receivable	0.00	0.00	0.00
Accounts Receivable	0.00	2.38	0.29
Inventories, net	32	20	18
Other Current Assets	-	5.58	7.49
Plant, Property, & Equipment, net	0.00	0.00	0.00
Total Noncurrent Assets	541	605	623
Long-Term Investments	187	326	299
Other Noncurrent Operating Assets	354	278	324
Total Liabilities & Shareholders' Equity	529	657	665
Total Liabilities	172	155	170
Total Current Liabilities	84	30	48
Accounts Payable	43	23	28
Current Deferred Revenue	6.16	0.00	3.54
Current Deferred & Payable Income Tax Liabilities	7.66	1.60	4.48
Other Current Liabilities	18	5.74	11
Total Noncurrent Liabilities	88	125	122
Long-Term Debt	54	40	40
Asset Retirement Reserve & Litigation Obligation	29	40	41
Noncurrent Deferred & Payable Income Tax Liabilities	0.16	41	37
Other Noncurrent Operating Liabilities	4.86	4.33	4.25
Total Equity & Noncontrolling Interests	356	502	495
Total Preferred & Common Equity	323	502	495
Total Common Equity	323	502	495
Common Stock	1,644	1,768	1,805
Retained Earnings	-1,321	-1,266	-1,310

This table presents McEwen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	545	678	593	573	639	645	668
Total Current Assets	96	223	145	126	52	72	60
Cash & Equivalents	55	191	85	49	22	41	29
Short-Term Investments	1.43	1.59	29	41	1.57	1.95	1.00
Note & Lease Receivable	-	-	-	-	0.00	0.00	0.00
Accounts Receivable	-	-	-	-	2.75	3.15	0.00
Inventories, net	30	24	24	27	20	20	22
Other Current Assets	-	-	-	8.68	5.84	6.39	7.41
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	449	454	448	447	587	573	608
Long-Term Investments	93	90	89	86	308	291	303
Other Noncurrent Operating Assets	356	364	359	361	279	282	305
Total Liabilities & Shareholders' Equity	545	678	593	573	639	645	668
Total Liabilities	147	172	131	139	156	160	166
Total Current Liabilities	58	89	53	53	38	43	51
Short-Term Debt	4.00	16	0.00	0.00	3.00	6.00	9.00
Accounts Payable	31	46	35	39	25	25	29
Current Deferred & Payable Income Tax Liabilities	-	8.23	0.61	0.61	1.98	2.46	3.05
Other Current Liabilities	19	17	12	3.85	6.23	9.78	10
Total Noncurrent Liabilities	89	83	78	85	118	117	115
Long-Term Debt	60	48	40	40	37	34	31
Asset Retirement Reserve & Litigation Obligation	25	29	33	40	39	42	41
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	38	36	37
Other Noncurrent Operating Liabilities	3.72	5.48	5.14	5.44	4.37	5.01	5.82
Total Equity & Noncontrolling Interests	398	505	462	434	483	485	502
Total Preferred & Common Equity	360	390	368	350	483	485	502
Total Common Equity	360	390	368	350	483	485	502
Common Stock	1,644	1,754	1,754	1,754	1,769	1,785	1,804
Retained Earnings	-1,284	-1,364	-1,386	-1,404	-1,286	-1,299	-1,301

This table displays calculated financial ratios and metrics derived from McEwen's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-19.13%	50.55%	4.96%
EBITDA Growth	-62.17%	-205.25%	93.02%
EBIT Growth	-25.00%	-164.89%	78.05%
NOPAT Growth	-48.47%	-20.06%	55.86%
Net Income Growth	-51.35%	138.54%	-231.69%
EPS Growth	-36.80%	167.84%	-174.14%
Operating Cash Flow Growth	-182.01%	29.95%	174.31%
Free Cash Flow Firm Growth	-26.96%	122.12%	-561.24%
Invested Capital Growth	-1.20%	-32.97%	15.25%
Revenue Q/Q Growth	-5.74%	22.42%	-12.60%
EBITDA Q/Q Growth	-29.64%	-7.90%	76.79%
EBIT Q/Q Growth	-15.15%	-5.81%	46.44%
NOPAT Q/Q Growth	-21.16%	25.53%	44.49%
Net Income Q/Q Growth	-32.37%	122.10%	-141.31%
EPS Q/Q Growth	-25.74%	145.67%	-143.43%
Operating Cash Flow Q/Q Growth	11.05%	20.26%	-37.03%
Free Cash Flow Firm Q/Q Growth	14.19%	115.13%	-351.02%
Invested Capital Q/Q Growth	-8.72%	-35.72%	5.91%
Profitability Metrics	-	-	-
Gross Margin	-0.49%	10.70%	17.73%
EBITDA Margin	-47.97%	-97.26%	-6.47%
Operating Margin	-86.43%	-97.49%	-28.98%
EBIT Margin	-65.66%	-115.53%	-24.15%
Profit (Net Income) Margin	-77.97%	19.96%	-25.04%
Tax Burden Percent	107.23%	49.49%	93.48%
Interest Burden Percent	110.74%	-34.91%	110.90%
Effective Tax Rate	0.00%	50.51%	0.00%
Return on Invested Capital (ROIC)	-23.24%	-33.61%	-17.18%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.72%	-93.06%	-14.34%
Return on Net Nonoperating Assets (RNNOA)	0.16%	41.34%	8.41%
Return on Equity (ROE)	-23.07%	7.73%	-8.76%
Cash Return on Invested Capital (CROIC)	-22.03%	5.87%	-31.35%
Operating Return on Assets (OROA)	-13.76%	-32.39%	-6.38%
Return on Assets (ROA)	-16.34%	5.60%	-6.61%
Return on Common Equity (ROCE)	-21.58%	7.43%	-8.76%
Return on Equity Simple (ROE_SIMPLE)	-26.67%	6.60%	-8.83%
Net Operating Profit after Tax (NOPAT)	-67	-80	-35
NOPAT Margin	-60.50%	-48.25%	-20.29%
Net Nonoperating Expense Percent (NNEP)	-22.52%	59.45%	-2.83%
Return On Investment Capital (ROIC_SIMPLE)	-15.90%	-14.79%	-6.62%
Cost of Revenue to Revenue	100.49%	89.30%	82.27%
SG&A Expenses to Revenue	10.77%	9.29%	9.84%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	85.94%	108.19%	46.72%
Earnings before Interest and Taxes (EBIT)	-72	-192	-42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-53	-162	-11
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.86	0.68	0.83
Price to Tangible Book Value (P/TBV)	0.86	0.68	0.83
Price to Revenue (P/Rev)	2.52	2.06	2.36
Price to Earnings (P/E)	0.00	6.19	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	16.15%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.52	0.16	0.62
Enterprise Value to Revenue (EV/Rev)	1.33	0.19	0.79
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	4.67
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	2.25	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.18	0.08	0.08
Long-Term Debt to Equity	0.15	0.08	0.08
Financial Leverage	-0.23	-0.44	-0.59
Leverage Ratio	1.41	1.38	1.33
Compound Leverage Factor	1.56	-0.48	1.47
Debt to Total Capital	15.22%	7.37%	7.48%
Short-Term Debt to Total Capital	2.38%	0.00%	0.00%
Long-Term Debt to Total Capital	12.84%	7.37%	7.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.96%	0.00%	0.00%
Common Equity to Total Capital	76.81%	92.63%	92.52%
Debt to EBITDA	-1.21	-0.25	-3.55
Net Debt to EBITDA	3.10	1.92	24.31
Long-Term Debt to EBITDA	-1.02	-0.25	-3.55
Debt to NOPAT	-0.96	-0.50	-1.13
Net Debt to NOPAT	2.45	3.88	7.75
Long-Term Debt to NOPAT	-0.81	-0.50	-1.13
Altman Z-Score	-2.78	-2.04	-1.26
Noncontrolling Interest Sharing Ratio	6.46%	3.90%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	0.97	1.76	0.86
Quick Ratio	0.49	0.90	0.33
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-63	14	-65
Operating Cash Flow to CapEx	-233.93%	-151.87%	68.35%
Free Cash Flow to Firm to Interest Expense	-8.13	0.00	-14.06
Operating Cash Flow to Interest Expense	-7.26	0.00	6.41
Operating Cash Flow Less CapEx to Interest Expense	-10.37	0.00	-2.97
Efficiency Ratios	-	-	-
Asset Turnover	0.21	0.28	0.26
Accounts Receivable Turnover	0.00	0.00	131.09
Inventory Turnover	4.67	5.75	7.54
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	2.70	4.56	5.62
Days Sales Outstanding (DSO)	0.00	0.00	2.78
Days Inventory Outstanding (DIO)	78.17	63.53	48.38
Days Payable Outstanding (DPO)	135.09	80.13	64.97
Cash Conversion Cycle (CCC)	-56.92	-16.59	-13.81
Capital & Investment Metrics	-	-	-
Invested Capital	286	192	221
Invested Capital Turnover	0.38	0.70	0.85
Increase / (Decrease) in Invested Capital	-3.48	-94	29
Enterprise Value (EV)	147	32	137
Market Capitalization	278	342	412
Book Value per Share	$6.81	$10.58	$9.35
Tangible Book Value per Share	$6.81	$10.58	$9.35
Total Capital	420	542	535
Total Debt	64	40	40
Total Long-Term Debt	54	40	40
Net Debt	-164	-311	-274
Capital Expenditures (CapEx)	24	26	43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-34	-2.11	-22
Debt-free Net Working Capital (DFNWC)	7.47	23	-6.50
Net Working Capital (NWC)	-2.53	23	-6.50
Net Nonoperating Expense (NNE)	19	-113	8.29
Net Nonoperating Obligations (NNO)	-71	-311	-274
Total Depreciation and Amortization (D&A)	20	30	31
Debt-free, Cash-free Net Working Capital to Revenue	-30.44%	-1.27%	-12.50%
Debt-free Net Working Capital to Revenue	6.76%	13.63%	-3.73%
Net Working Capital to Revenue	-2.29%	13.63%	-3.73%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.71)	$1.16	($0.86)
Adjusted Weighted Average Basic Shares Outstanding	47.43M	47.54M	51.02M
Adjusted Diluted Earnings per Share	($1.71)	$1.16	($0.86)
Adjusted Weighted Average Diluted Shares Outstanding	47.43M	47.54M	51.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.43M	49.44M	53.93M
Normalized Net Operating Profit after Tax (NOPAT)	-67	-113	-35
Normalized NOPAT Margin	-60.50%	-68.24%	-20.29%
Pre Tax Income Margin	-72.71%	40.33%	-26.79%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-9.31	0.00	-9.17
NOPAT to Interest Expense	-8.58	0.00	-7.70
EBIT Less CapEx to Interest Expense	-12.41	0.00	-18.55
NOPAT Less CapEx to Interest Expense	-11.68	0.00	-17.08
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from McEwen's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-30.01%	-19.24%	36.06%	12.23%	47.78%	107.79%	18.63%	38.03%	36.05%	-42.87%
EBITDA Growth	57.54%	-94.84%	-129.36%	-719.21%	-565.40%	-47.60%	61.64%	89.38%	128.70%	101.63%
EBIT Growth	42.80%	-42.02%	-124.38%	-502.65%	-321.11%	-32.72%	51.40%	78.98%	99.53%	85.39%
NOPAT Growth	10.65%	-74.03%	-77.66%	-159.59%	-85.14%	-37.12%	48.68%	67.57%	99.66%	72.93%
Net Income Growth	39.42%	-100.12%	-72.85%	-248.71%	-169.14%	435.59%	44.02%	69.96%	92.67%	-105.83%
EPS Growth	42.11%	-71.74%	-102.22%	-76.92%	-77.27%	468.35%	54.95%	43.48%	89.74%	-105.15%
Operating Cash Flow Growth	6.51%	712.16%	-24.81%	7.47%	77.84%	166.63%	119.91%	110.61%	1,116.62%	-107.52%
Free Cash Flow Firm Growth	-531.27%	-16.01%	-266.36%	9.99%	82.81%	336.36%	345.02%	542.59%	1,859.57%	-169.59%
Invested Capital Growth	6.34%	-1.20%	1.06%	-2.57%	-4.83%	-32.97%	-33.53%	-36.09%	-30.04%	15.25%
Revenue Q/Q Growth	-15.20%	8.67%	23.06%	-1.03%	11.66%	52.80%	-29.74%	15.15%	10.06%	-35.84%
EBITDA Q/Q Growth	33.51%	-443.80%	-53.33%	-47.77%	46.00%	-20.63%	60.15%	59.10%	246.00%	-93.13%
EBIT Q/Q Growth	14.10%	-248.63%	-40.83%	-42.89%	39.98%	-9.87%	48.43%	38.21%	98.66%	-3,317.49%
NOPAT Q/Q Growth	5.99%	-151.54%	-9.31%	-0.42%	32.95%	-86.30%	59.09%	36.55%	99.30%	-14,895.88%
Net Income Q/Q Growth	15.03%	-299.18%	13.48%	-18.82%	34.41%	597.73%	-114.43%	36.25%	83.99%	-295.58%
EPS Q/Q Growth	15.38%	-259.09%	-15.19%	49.45%	15.22%	846.15%	-114.09%	36.59%	84.62%	-275.00%
Operating Cash Flow Q/Q Growth	71.98%	158.73%	-422.66%	-74.26%	93.29%	806.58%	-75.91%	-7.09%	542.79%	-105.23%
Free Cash Flow Firm Q/Q Growth	-19.85%	18.98%	-37.77%	32.71%	77.11%	1,213.63%	42.82%	21.54%	-8.98%	-144.04%
Invested Capital Q/Q Growth	1.90%	-8.72%	0.46%	4.26%	-0.46%	-35.72%	-0.36%	0.23%	8.97%	5.91%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	5.78%	-1.02%	12.78%	-10.08%	9.78%	22.24%	14.58%	22.66%	26.42%	1.08%
EBITDA Margin	-17.60%	-88.10%	-109.77%	-163.89%	-79.27%	-62.58%	-35.50%	-12.61%	16.72%	1.79%
Operating Margin	-59.94%	-138.75%	-123.25%	-125.05%	-75.10%	-80.74%	-53.32%	-29.38%	-0.19%	-43.39%
EBIT Margin	-35.59%	-114.18%	-130.67%	-188.65%	-101.42%	-72.93%	-53.53%	-28.72%	-0.35%	-18.66%
Profit (Net Income) Margin	-40.56%	-149.02%	-104.77%	-125.78%	-73.88%	240.66%	-49.44%	-27.37%	-3.98%	-24.56%
Tax Burden Percent	95.26%	120.45%	98.55%	95.48%	99.15%	79.38%	88.85%	84.54%	164.25%	114.96%
Interest Burden Percent	119.65%	108.35%	81.36%	69.83%	73.47%	-415.73%	103.94%	112.72%	692.35%	114.50%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	20.62%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-16.18%	-37.31%	-36.14%	-35.62%	-23.37%	-44.65%	-26.98%	-15.58%	-0.10%	-25.71%
ROIC Less NNEP Spread (ROIC-NNEP)	-16.54%	-20.19%	-32.04%	-24.54%	-15.97%	-138.41%	-25.02%	-14.16%	0.83%	-26.38%
Return on Net Nonoperating Assets (RNNOA)	4.13%	4.64%	11.36%	6.91%	4.25%	61.49%	12.92%	6.83%	-0.38%	15.48%
Return on Equity (ROE)	-12.06%	-32.67%	-24.79%	-28.71%	-19.12%	16.84%	-14.06%	-8.75%	-0.49%	-10.24%
Cash Return on Invested Capital (CROIC)	-24.30%	-22.03%	-29.04%	-29.85%	-30.31%	5.87%	4.39%	11.30%	10.17%	-31.35%
Operating Return on Assets (OROA)	-7.69%	-23.92%	-25.76%	-41.79%	-24.64%	-20.44%	-14.05%	-8.62%	-0.11%	-4.92%
Return on Assets (ROA)	-8.76%	-31.22%	-20.66%	-27.86%	-17.95%	67.47%	-12.97%	-8.21%	-1.28%	-6.48%
Return on Common Equity (ROCE)	-11.27%	-30.56%	-21.18%	-24.76%	-16.31%	16.18%	-12.42%	-7.88%	-0.44%	-10.24%
Return on Equity Simple (ROE_SIMPLE)	-18.06%	0.00%	-26.03%	-35.94%	-42.90%	0.00%	10.20%	16.38%	21.06%	0.00%
Net Operating Profit after Tax (NOPAT)	-11	-27	-30	-30	-20	-38	-15	-9.76	-0.07	-10
NOPAT Margin	-41.96%	-97.12%	-86.27%	-87.54%	-52.57%	-64.09%	-37.32%	-20.56%	-0.13%	-30.37%
Net Nonoperating Expense Percent (NNEP)	0.36%	-17.11%	-4.10%	-11.07%	-7.40%	93.76%	-1.96%	-1.42%	-0.94%	0.67%
Return On Investment Capital (ROIC_SIMPLE)	-2.36%	-6.53%	-5.27%	-6.00%	-4.26%	-6.93%	-2.94%	-1.86%	-0.01%	-1.90%
Cost of Revenue to Revenue	94.22%	101.02%	87.22%	110.08%	90.22%	77.76%	85.42%	77.34%	73.58%	98.92%
SG&A Expenses to Revenue	16.75%	10.98%	9.90%	5.96%	9.69%	10.63%	9.88%	9.40%	4.09%	19.37%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	65.72%	137.73%	136.03%	114.97%	84.87%	102.98%	67.90%	52.04%	26.60%	44.47%
Earnings before Interest and Taxes (EBIT)	-9.25	-32	-45	-65	-39	-43	-22	-14	-0.18	-6.25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.58	-25	-38	-56	-30	-37	-15	-5.99	8.74	0.60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.43	0.86	1.03	0.93	0.88	0.68	1.01	0.00	0.95	0.83
Price to Tangible Book Value (P/TBV)	0.43	0.86	1.03	0.93	0.88	0.68	1.01	0.00	0.95	0.83
Price to Revenue (P/Rev)	1.32	2.52	3.36	2.76	2.27	2.06	2.82	0.00	2.38	2.36
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	6.19	6.25	0.00	4.61	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	16.15%	16.00%	0.00%	21.68%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.34	0.52	1.04	0.91	0.86	0.16	1.03	0.00	0.87	0.62
Enterprise Value to Revenue (EV/Rev)	0.92	1.33	2.50	2.21	1.89	0.19	1.13	0.00	0.91	0.79
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.88	4.67
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	2.25	18.65	0.00	7.05	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.18	0.13	0.09	0.09	0.08	0.08	0.08	0.08	0.08
Long-Term Debt to Equity	0.15	0.15	0.10	0.09	0.09	0.08	0.08	0.07	0.06	0.08
Financial Leverage	-0.25	-0.23	-0.35	-0.28	-0.27	-0.44	-0.52	-0.48	-0.46	-0.59
Leverage Ratio	1.34	1.41	1.37	1.32	1.34	1.38	1.33	1.31	1.33	1.33
Compound Leverage Factor	1.60	1.53	1.12	0.92	0.99	-5.74	1.39	1.47	9.18	1.52
Debt to Total Capital	13.81%	15.22%	11.26%	7.97%	8.44%	7.37%	7.66%	7.62%	7.38%	7.48%
Short-Term Debt to Total Capital	0.87%	2.38%	2.81%	0.00%	0.00%	0.00%	0.57%	1.14%	1.66%	0.00%
Long-Term Debt to Total Capital	12.95%	12.84%	8.45%	7.97%	8.44%	7.37%	7.08%	6.47%	5.72%	7.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	8.26%	7.96%	20.30%	18.72%	17.73%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	77.93%	76.81%	68.44%	73.32%	73.83%	92.63%	92.34%	92.38%	92.62%	92.52%
Debt to EBITDA	-1.56	-1.21	-0.86	-0.32	-0.27	-0.25	-0.29	-0.46	-0.82	-3.55
Net Debt to EBITDA	2.09	3.10	2.93	1.31	0.91	1.92	2.11	3.35	6.04	24.31
Long-Term Debt to EBITDA	-1.46	-1.02	-0.65	-0.32	-0.27	-0.25	-0.27	-0.39	-0.64	-3.55
Debt to NOPAT	-1.16	-0.96	-0.80	-0.41	-0.37	-0.50	-0.47	-0.50	-0.63	-1.13
Net Debt to NOPAT	1.55	2.45	2.73	1.65	1.26	3.88	3.40	3.66	4.61	7.75
Long-Term Debt to NOPAT	-1.09	-0.81	-0.60	-0.41	-0.37	-0.50	-0.43	-0.42	-0.49	-1.13
Altman Z-Score	-2.42	-2.53	-1.23	-1.68	-1.93	-1.29	-0.76	0.00	-0.69	-1.08
Noncontrolling Interest Sharing Ratio	6.56%	6.46%	14.54%	13.75%	14.69%	3.90%	11.70%	9.92%	8.98%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.65	0.97	2.50	2.74	2.35	1.76	1.37	1.68	1.17	0.86
Quick Ratio	0.97	0.49	2.15	2.16	1.68	0.90	0.69	1.06	0.59	0.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-30	-24	-33	-22	-5.08	57	81	98	89	-39
Operating Cash Flow to CapEx	-115.74%	85.74%	-393.84%	-847.60%	-24.47%	205.96%	85.82%	53.95%	121.10%	-9.51%
Free Cash Flow to Firm to Interest Expense	-16.27	-8.89	0.00	0.00	0.00	38.93	92.93	56.67	82.51	-43.43
Operating Cash Flow to Interest Expense	-5.66	2.24	0.00	0.00	0.00	11.08	4.46	2.08	21.38	-1.34
Operating Cash Flow Less CapEx to Interest Expense	-10.55	-0.37	0.00	0.00	0.00	5.70	-0.74	-1.78	3.73	-15.39
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.21	0.20	0.22	0.24	0.28	0.26	0.30	0.32	0.26
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	131.09
Inventory Turnover	3.34	4.67	5.51	5.66	4.58	5.75	7.06	6.91	6.36	7.54
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	2.67	2.70	2.48	3.98	3.79	4.56	4.33	5.08	4.61	5.62
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.78
Days Inventory Outstanding (DIO)	109.41	78.17	66.28	64.47	79.64	63.53	51.68	52.81	57.43	48.38
Days Payable Outstanding (DPO)	136.85	135.09	147.34	91.75	96.32	80.13	84.36	71.80	79.13	64.97
Cash Conversion Cycle (CCC)	-27.44	-56.92	-81.06	-27.28	-16.68	-16.59	-32.67	-18.99	-21.70	-13.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	313	286	287	299	298	192	191	191	208	221
Invested Capital Turnover	0.39	0.38	0.42	0.41	0.44	0.70	0.72	0.76	0.79	0.85
Increase / (Decrease) in Invested Capital	19	-3.48	3.01	-7.91	-15	-94	-96	-108	-90	29
Enterprise Value (EV)	107	147	299	272	257	32	196	0.00	181	137
Market Capitalization	155	278	402	341	309	342	487	0.00	475	412
Book Value per Share	$7.59	$6.81	$8.22	$7.76	$7.37	$10.58	$9.76	$9.76	$9.83	$9.35
Tangible Book Value per Share	$7.59	$6.81	$8.22	$7.76	$7.37	$10.58	$9.76	$9.76	$9.83	$9.35
Total Capital	462	420	569	502	474	542	523	525	542	535
Total Debt	64	64	64	40	40	40	40	40	40	40
Total Long-Term Debt	60	54	48	40	40	40	37	34	31	40
Net Debt	-85	-164	-218	-163	-136	-311	-292	-294	-294	-274
Capital Expenditures (CapEx)	8.89	7.05	4.95	4.01	9.32	7.82	4.52	6.68	19	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-14	-34	-42	-22	-18	-2.11	-6.45	-7.49	-13	-22
Debt-free Net Working Capital (DFNWC)	42	7.47	150	92	72	23	17	35	18	-6.50
Net Working Capital (NWC)	38	-2.53	134	92	72	23	14	29	8.64	-6.50
Net Nonoperating Expense (NNE)	-0.36	15	6.43	13	8.19	-179	5.00	3.23	2.01	-1.95
Net Nonoperating Obligations (NNO)	-85	-71	-218	-163	-136	-311	-292	-294	-294	-274
Total Depreciation and Amortization (D&A)	4.67	7.37	7.26	8.52	8.51	6.07	7.44	7.65	8.92	6.85
Debt-free, Cash-free Net Working Capital to Revenue	-12.21%	-30.44%	-35.35%	-17.82%	-12.98%	-1.27%	-3.73%	-4.03%	-6.31%	-12.50%
Debt-free Net Working Capital to Revenue	35.86%	6.76%	125.46%	74.59%	53.26%	13.63%	9.91%	18.91%	8.83%	-3.73%
Net Working Capital to Revenue	32.45%	-2.29%	112.08%	74.59%	53.26%	13.63%	8.17%	15.68%	4.33%	-3.73%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.21)	($0.79)	($0.91)	($0.46)	($0.39)	$2.91	($0.41)	($0.26)	($0.04)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	50.78M	47.43M	47.43M	47.43M	47.47M	47.54M	49.44M	49.72M	51.95M	51.02M
Adjusted Diluted Earnings per Share	($0.21)	($0.79)	($0.91)	($0.46)	($0.39)	$2.91	($0.41)	($0.26)	($0.04)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	50.78M	47.43M	47.43M	47.43M	47.47M	47.54M	49.44M	49.72M	51.95M	51.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	($0.79)	$0.00	$0.00	$0.00	$2.91	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.43M	47.43M	47.43M	47.47M	47.49M	49.44M	49.44M	51.09M	52.92M	53.93M
Normalized Net Operating Profit after Tax (NOPAT)	-11	-27	-30	-30	-20	-38	-15	-9.76	-0.07	-10
Normalized NOPAT Margin	-41.96%	-97.12%	-86.27%	-87.54%	-52.57%	-64.09%	-37.32%	-20.56%	-0.13%	-30.37%
Pre Tax Income Margin	-42.58%	-123.72%	-106.31%	-131.73%	-74.52%	303.19%	-55.64%	-32.38%	-2.42%	-21.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.09	-11.97	0.00	0.00	0.00	-29.43	-25.37	-7.86	-0.17	-6.90
NOPAT to Interest Expense	-6.00	-10.18	0.00	0.00	0.00	-25.87	-17.69	-5.63	-0.06	-11.23
EBIT Less CapEx to Interest Expense	-9.98	-14.59	0.00	0.00	0.00	-34.81	-30.57	-11.72	-17.83	-20.95
NOPAT Less CapEx to Interest Expense	-10.89	-12.80	0.00	0.00	0.00	-31.25	-22.88	-9.48	-17.72	-25.28
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Key Financial Trends

McEwen Mining Inc. (NYSE:MUX) has experienced significant volatility in its financial performance over the past four years, as reflected in quarterly income statements, cash flow statements, and balance sheets.

Positive Highlights:

In Q4 2023, McEwen delivered a strong quarter with a net income of $138.5 million attributable to common shareholders and positive diluted earnings per share of $2.91, reflecting a significant turnaround compared to prior quarters.
The company reported strong operating cash flow in several quarters, notably $23.2 million in Q3 2024 and $38.8 million in Q1 2024, indicating healthy cash generation from operations during those periods.
Total assets increased from $545 million in Q3 2022 to approximately $668 million in Q3 2024, showcasing asset growth driven by long-term investments and other noncurrent operating assets.
McEwen maintained substantial liquidity, with cash and equivalents around $29 million as of Q3 2024 and even higher in prior periods, supporting operational and investing activities.
The company has been actively investing in property, plant, and equipment, especially in Q3 2024 ($19.1 million) and Q4 2023 ($7.8 million), which could support future production growth and revenue expansion.

Neutral Observations:

Operating revenues have fluctuated across quarters, with highs such as $58.7 million in Q4 2023 and lows like $28.2 million in Q4 2022, suggesting variability in production volumes or commodity prices impacting sales.
Long-term debt levels have remained relatively steady around $30 million to $48 million over recent quarters, reflecting consistent debt management without dramatic increases or repayments.
The weighted average shares outstanding have gradually increased from about 47 million shares in 2022 to over 51 million in recent quarters, likely due to equity financing or share issuances, which mildly dilutes earnings per share.
Interest expense fluctuated but remained a notable line item, ranging roughly from $870,000 to over $1.7 million, impacting net income but manageable relative to revenues.

Negative Concerns:

McEwen reported net losses in many quarters throughout 2023 and 2024, including a sizeable consolidated net loss of $8.2 million in Q4 2024 and losses exceeding $20 million in several other recent quarters, leading to negative earnings per share (e.g., -$0.15 in Q4 2024 and -$0.41 in Q1 2024).
Operating expenses, especially "Other Operating Expenses," have been exceptionally high, reaching $50.2 million in Q4 2023 and similar levels previously, significantly weighing on operating income and profitability.
Capital expenditures and investing activities resulted in sizable cash outflows quarter-over-quarter, such as $45 million in acquisitions during Q4 2023 and over $19 million spent on property and equipment in Q3 2024, exerting pressure on cash flows.
The company experienced substantial negative cash flow from investing activities frequently, e.g., -$47 million in Q4 2023 and -$34 million in Q3 2024, potentially increasing future risk if investments do not translate into increased revenues.
Despite asset growth, retained earnings remain deeply negative (e.g., -$1.3 billion in Q3 2024), indicating an accumulated deficit that could limit financial flexibility.

In summary, McEwen Mining Inc. has shown periods of strong operational cash flow and asset growth, supported by ongoing investments in its operations. However, consistent net losses, high operating expenses, and negative retained earnings highlight ongoing challenges in achieving sustained profitability. Investors should monitor how the company manages its expenses, investment returns, and earnings over the coming quarters to assess potential for recovery and growth.

08/08/25 07:44 PMAI Generated. May Contain Errors.

Frequently Asked Questions About McEwen's Financials

When does McEwen's financial year end?

According to the most recent income statement we have on file, McEwen's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has McEwen's net income changed over the last 2 years?

McEwen's net income appears to be on a downward trend, with a most recent value of -$43.69 million in 2024, falling from -$86.09 million in 2022. The previous period was $33.18 million in 2023. See where experts think McEwen is headed by visiting McEwen's forecast page.

What is McEwen's operating income?

McEwen's total operating income in 2024 was -$50.57 million, based on the following breakdown:

Total Gross Profit: $30.94 million
Total Operating Expenses: $81.51 million

How has McEwen's revenue changed over the last 2 years?

Over the last 2 years, McEwen's total revenue changed from $110.42 million in 2022 to $174.48 million in 2024, a change of 58.0%.

How much debt does McEwen have?

McEwen's total liabilities were at $169.65 million at the end of 2024, a 9.6% increase from 2023, and a 1.6% decrease since 2022.

How much cash does McEwen have?

In the past 2 years, McEwen's cash and equivalents has ranged from $13.69 million in 2024 to $39.78 million in 2022, and is currently $13.69 million as of their latest financial filing in 2024.

How has McEwen's book value per share changed over the last 2 years?

Over the last 2 years, McEwen's book value per share changed from 6.81 in 2022 to 9.35 in 2024, a change of 37.4%.

Related Companies

This page (NYSE:MUX) was last updated on 8/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McEwen (MUX) Financials

Key Financial Trends

Frequently Asked Questions About McEwen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McEwen (MUX) Financials

Annual Income Statements for McEwen

Quarterly Income Statements for McEwen

Annual Cash Flow Statements for McEwen

Quarterly Cash Flow Statements for McEwen

Annual Balance Sheets for McEwen

Quarterly Balance Sheets for McEwen

Annual Metrics And Ratios for McEwen

Quarterly Metrics And Ratios for McEwen

Key Financial Trends

Frequently Asked Questions About McEwen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools